Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence. / Pedersen, Kasper Mønsted; Çolak, Yunus; Vedel-Krogh, Signe; Kobylecki, Camilla Jannie; Bojesen, Stig Egil; Nordestgaard, Børge Grønne.

In: European Journal of Epidemiology, Vol. 37, 2022, p. 735–745.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Pedersen, KM, Çolak, Y, Vedel-Krogh, S, Kobylecki, CJ, Bojesen, SE & Nordestgaard, BG 2022, 'Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence', European Journal of Epidemiology, vol. 37, pp. 735–745. https://doi.org/10.1007/s10654-021-00763-3

APA

Pedersen, K. M., Çolak, Y., Vedel-Krogh, S., Kobylecki, C. J., Bojesen, S. E., & Nordestgaard, B. G. (2022). Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence. European Journal of Epidemiology, 37, 735–745. https://doi.org/10.1007/s10654-021-00763-3

Vancouver

Pedersen KM, Çolak Y, Vedel-Krogh S, Kobylecki CJ, Bojesen SE, Nordestgaard BG. Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence. European Journal of Epidemiology. 2022;37:735–745. https://doi.org/10.1007/s10654-021-00763-3

Author

Pedersen, Kasper Mønsted ; Çolak, Yunus ; Vedel-Krogh, Signe ; Kobylecki, Camilla Jannie ; Bojesen, Stig Egil ; Nordestgaard, Børge Grønne. / Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence. In: European Journal of Epidemiology. 2022 ; Vol. 37. pp. 735–745.

Bibtex

@article{f7a084c5feec45458d12dac53dcd3c22,
title = "Risk of ulcerative colitis and Crohn{\textquoteright}s disease in smokers lacks causal evidence",
abstract = "Smoking has been associated with opposing risks of ulcerative colitis and Crohn{\textquoteright}s disease. Whether these observational associations reflect actual causal associations, confounding, or reverse causation is unclear. Using a Mendelian randomization approach, we tested the hypothesis that smoking protects against ulcerative colitis and is a cause of Crohn{\textquoteright}s disease. We included 118,683 white Danes aged ≥ 20 from the Copenhagen General Population Study (2003–2015) and the Copenhagen City Heart Study (1991–94 and 2001–03). During follow-up until 2018, we investigated the association of smoking and CHRNA3 rs1051730, where the T-allele is strongly associated with nicotine dependence, with risk of ulcerative colitis and Crohn{\textquoteright}s disease. We identified 1312 cases of ulcerative colitis and 671 cases of Crohn{\textquoteright}s disease. Compared to never-smokers, multivariable adjusted hazard ratios (HRs) for ulcerative colitis were 1.69(95% confidence interval [CI] 1.32–2.15) in former smokers and 2.27(1.74–2.96) in current smokers. Corresponding HRs for Crohn{\textquoteright}s disease were 1.31(0.93–1.84) and 1.93(1.34–2.78), respectively. Among ever-smokers when compared to non-carriers of the CHRNA3 rs1051730 T-allele, age and sex adjusted HRs for risk of ulcerative colitis were 1.03(95%CI 0.89–1.18) in heterozygotes and 0.91(0.72–1.16) in homozygotes. Corresponding HRs for Crohn{\textquoteright}s disease were 1.05(0.87–1.28) and 1.02(0.74–1.41), respectively. In a meta-analysis combined with UK Biobank, there was no evidence that CHRNA3 rs1051730 was associated with risk of ulcerative colitis or Crohn{\textquoteright}s disease. In conclusion, current versus never-smoking was associated with unexpected 2.3-fold risk of ulcerative colitis and expected 1.9-fold risk of Crohn{\textquoteright}s disease in prospective analyses; however, genetic evidence of lifelong increased smoking intensity did not support causal relationships.",
keywords = "Crohn{\textquoteright}s disease, Epidemiology, Mendelian randomization, Smoking, Ulcerative colitis",
author = "Pedersen, {Kasper M{\o}nsted} and Yunus {\c C}olak and Signe Vedel-Krogh and Kobylecki, {Camilla Jannie} and Bojesen, {Stig Egil} and Nordestgaard, {B{\o}rge Gr{\o}nne}",
note = "Publisher Copyright: {\textcopyright} 2021, Springer Nature B.V.",
year = "2022",
doi = "10.1007/s10654-021-00763-3",
language = "English",
volume = "37",
pages = "735–745",
journal = "European Journal of Epidemiology",
issn = "0393-2990",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence

AU - Pedersen, Kasper Mønsted

AU - Çolak, Yunus

AU - Vedel-Krogh, Signe

AU - Kobylecki, Camilla Jannie

AU - Bojesen, Stig Egil

AU - Nordestgaard, Børge Grønne

N1 - Publisher Copyright: © 2021, Springer Nature B.V.

PY - 2022

Y1 - 2022

N2 - Smoking has been associated with opposing risks of ulcerative colitis and Crohn’s disease. Whether these observational associations reflect actual causal associations, confounding, or reverse causation is unclear. Using a Mendelian randomization approach, we tested the hypothesis that smoking protects against ulcerative colitis and is a cause of Crohn’s disease. We included 118,683 white Danes aged ≥ 20 from the Copenhagen General Population Study (2003–2015) and the Copenhagen City Heart Study (1991–94 and 2001–03). During follow-up until 2018, we investigated the association of smoking and CHRNA3 rs1051730, where the T-allele is strongly associated with nicotine dependence, with risk of ulcerative colitis and Crohn’s disease. We identified 1312 cases of ulcerative colitis and 671 cases of Crohn’s disease. Compared to never-smokers, multivariable adjusted hazard ratios (HRs) for ulcerative colitis were 1.69(95% confidence interval [CI] 1.32–2.15) in former smokers and 2.27(1.74–2.96) in current smokers. Corresponding HRs for Crohn’s disease were 1.31(0.93–1.84) and 1.93(1.34–2.78), respectively. Among ever-smokers when compared to non-carriers of the CHRNA3 rs1051730 T-allele, age and sex adjusted HRs for risk of ulcerative colitis were 1.03(95%CI 0.89–1.18) in heterozygotes and 0.91(0.72–1.16) in homozygotes. Corresponding HRs for Crohn’s disease were 1.05(0.87–1.28) and 1.02(0.74–1.41), respectively. In a meta-analysis combined with UK Biobank, there was no evidence that CHRNA3 rs1051730 was associated with risk of ulcerative colitis or Crohn’s disease. In conclusion, current versus never-smoking was associated with unexpected 2.3-fold risk of ulcerative colitis and expected 1.9-fold risk of Crohn’s disease in prospective analyses; however, genetic evidence of lifelong increased smoking intensity did not support causal relationships.

AB - Smoking has been associated with opposing risks of ulcerative colitis and Crohn’s disease. Whether these observational associations reflect actual causal associations, confounding, or reverse causation is unclear. Using a Mendelian randomization approach, we tested the hypothesis that smoking protects against ulcerative colitis and is a cause of Crohn’s disease. We included 118,683 white Danes aged ≥ 20 from the Copenhagen General Population Study (2003–2015) and the Copenhagen City Heart Study (1991–94 and 2001–03). During follow-up until 2018, we investigated the association of smoking and CHRNA3 rs1051730, where the T-allele is strongly associated with nicotine dependence, with risk of ulcerative colitis and Crohn’s disease. We identified 1312 cases of ulcerative colitis and 671 cases of Crohn’s disease. Compared to never-smokers, multivariable adjusted hazard ratios (HRs) for ulcerative colitis were 1.69(95% confidence interval [CI] 1.32–2.15) in former smokers and 2.27(1.74–2.96) in current smokers. Corresponding HRs for Crohn’s disease were 1.31(0.93–1.84) and 1.93(1.34–2.78), respectively. Among ever-smokers when compared to non-carriers of the CHRNA3 rs1051730 T-allele, age and sex adjusted HRs for risk of ulcerative colitis were 1.03(95%CI 0.89–1.18) in heterozygotes and 0.91(0.72–1.16) in homozygotes. Corresponding HRs for Crohn’s disease were 1.05(0.87–1.28) and 1.02(0.74–1.41), respectively. In a meta-analysis combined with UK Biobank, there was no evidence that CHRNA3 rs1051730 was associated with risk of ulcerative colitis or Crohn’s disease. In conclusion, current versus never-smoking was associated with unexpected 2.3-fold risk of ulcerative colitis and expected 1.9-fold risk of Crohn’s disease in prospective analyses; however, genetic evidence of lifelong increased smoking intensity did not support causal relationships.

KW - Crohn’s disease

KW - Epidemiology

KW - Mendelian randomization

KW - Smoking

KW - Ulcerative colitis

U2 - 10.1007/s10654-021-00763-3

DO - 10.1007/s10654-021-00763-3

M3 - Journal article

C2 - 34091767

AN - SCOPUS:85107447544

VL - 37

SP - 735

EP - 745

JO - European Journal of Epidemiology

JF - European Journal of Epidemiology

SN - 0393-2990

ER -

ID: 303034610